An interventional study of Home visits and standard in Esophageal Cancer and Gastro-esophageal Junction Cancer, sponsored by Michael Bau Mortensen. Status unknown at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-11-23.
Sponsored by Michael Bau Mortensen · Not applicable, Interventional, and Supportive care
The aim of this study is to compare, specialist nurse home visits in patients with inoperable cancer in the esophagus or cardia, who are palliated with Self Expanding Metal Stent, to standard patient contact with regards to quality of life, number and character of reinterventions and cost-effectiveness.
The aim of this study is to compare, specialist nurse home visits in patients with inoperable cancer in the esophagus or gastro-esophageal junction (cardia), who are palliated with Self Expanding Metal Stent, to standard patient contact with regards to quality of life, number and character of reinterventions and cost-effectiveness.
1,593 studies on the registry are indexed under Esophageal Neoplasms; 460 are open to participants now.
This study's planned enrollment of 80 is above the median of 58 across 1,170 interventional studies indexed under Esophageal Neoplasms.
Browse Esophageal Neoplasms studies →Michael Bau Mortensen is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
After SEMS placement, 2 home visits and a phonecall are made by a specialist nurse
Behavioral: Home visits
Standard contact via Hotline and traditional referring methods
Behavioral: standard
home visits by specialist nurse 2 times and 1 phonecall
Also known as: Home visit,, pro active nurse care
hotline
Also known as: Phone Hotline, After hours phone line
HRQoL, EORTC C-30, EOS-18
Time frame: 2 years
This study is status unknown, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Michael Bau Mortensen